caris life sciences ipo nasdaq - Search News

News

IPO, Caris and Life Sciences

Fast Company · 7h

Caris Life Sciences IPO: All eyes on the stock price today as the AI cancer care firm makes its Nasdaq debut

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite for biotech IPOs.

The Dallas Morning News · 1h

Caris Life Sciences spikes by over 30% in IPO debut, embraces AI as future of oncology

The stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public offering at $21 per share and

Seeking Alpha on MSN · 11h

Cancer diagnostics firm Caris prices IPO at $21 per share

Caris Life Sciences (NASDAQ:CAI) is scheduled to make its trading debut on Wednesday on the Nasdaq after the Irving, Texas-based cancer diagnostics company priced its initial public offering at $21.00 per share,

5hon MSN

Sixth Street-backed Caris Life valued at $7.66 billion in strong Nasdaq debut

Caris Life Sciences' shares jumped nearly 29% in their Nasdaq debut on Wednesday, fetching the cancer diagnostic firm a ...

6h

DFW's newest public co. set to raise $494 million in IPO

The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about ...

Caris swells its planned IPO, seeking $5.7bn valuation

The IPO comes just a few weeks after Caris raised $168 million in a private financing round that took the total raised by the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results